4-(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)benzoic acid | 85292-42-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)benzoic acid
• 英文别名: 4-[5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzoic acid
• CAS: 85292-42-8
• 化学式: C₁₆H₁₂N₂O₄
• 分子量: 296.282
• InChiKey: INZGVNNPCAZRND-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  85.4
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)benzoic acid 在 氯化亚砜 作用下， 反应 0.5h， 以82%的产率得到4-[5-(4-Methoxy-phenyl)-[1,3,4]oxadiazol-2-yl]-benzoyl chloride
  参考文献：
  名称：

  Research in the 2,5-diaryl-1,3,4-oxadiazole series. 1. Electronic structures and spectral-luminescence properties of substituted 2,5-diphenyl-1,3,4-oxadiazoles

  摘要：

  DOI：

  10.1007/bf00512808
• 作为产物：
  描述：

  在 三氯氧磷 作用下， 反应 0.5h， 以68%的产率得到4-(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)benzoic acid
  参考文献：
  名称：

  Research in the 2,5-diaryl-1,3,4-oxadiazole series. 1. Electronic structures and spectral-luminescence properties of substituted 2,5-diphenyl-1,3,4-oxadiazoles

  摘要：

  DOI：

  10.1007/bf00512808

文献信息

• Symmetrical and non-symmetrical 2,5-diaryl-1,3,4-oxadiazoles: synthesis and photophysical properties
  作者：Codruţa C. Paraschivescu、Niculina D. Hădade、Anca G. Coman、Arnaud Gautier、Federico Cisnetti、Mihaela Matache

  DOI：10.1016/j.tetlet.2015.05.005

  日期：2015.6

  We report herein the synthesis of 2,5-diaryl-1,3,4-oxadiazoles containing both electron-donating and withdrawing substituents as well as bis- and tris-2,5-disubstituted-1,3,4-oxadiazoles containing electron-donating substituents. The photophysical properties of the synthesized compounds were studied using UV–Vis and fluorescence spectroscopy. The aryl substitution pattern was found to have a marked

  我们在此报告了既含给电子取代基又含吸电子取代基的2,5-二芳基-1,3,4-恶二唑以及含电子的双-和tris-2,5-二取代-1,3,4-恶二唑的合成-供体取代基。使用UV-Vis和荧光光谱法研究了合成化合物的光物理性质。发现芳基取代图案对发光效率和其他光物理性质均具有显着影响。给电子基团数和/或杂环数的增加提供了发射最大值的红移，以及斯托克斯位移的增加。对于在芳环上具有推挽式取代基的单1,3,4-恶二唑也观察到了相同的效果。
• Compounds for Nonsense Suppression, and Methods for Their Use
  申请人：Almstead Neil G.

  公开号：US20090253699A1

  公开（公告）日：2009-10-08

  The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.

  本发明涉及使用本发明的化合物或组合物治疗或预防与mRNA中无意义突变相关的疾病的方法、化合物和组合物。更具体地，本发明涉及用于抑制与mRNA中无意义突变相关的早期翻译终止的方法、化合物和组合物。
• METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCICATED THEREWITH
  申请人：Almstead Neil G.

  公开号：US20110046136A1

  公开（公告）日：2011-02-24

  The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene.

  本发明涉及由核酸序列编码的功能性蛋白质，其中包括一个无意义突变。本发明还涉及用于生产由包含无意义突变的核酸序列编码的功能性蛋白质的方法，以及利用这些蛋白质预防、管理和/或治疗与基因中的无意义突变相关的疾病。
• METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCIATED THEREWITH
  申请人：PTC THERAPEUTICS, INC

  公开号：US20160199357A1

  公开（公告）日：2016-07-14

  The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene.

  本发明涉及由包含无意义突变的核酸序列编码的功能蛋白质。本发明还涉及用于生产由包含无意义突变的核酸序列编码的功能蛋白质的方法，并使用这些蛋白质预防、管理和/或治疗与基因中的无意义突变相关的疾病。
• Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
  申请人：PTC Therapeutics, Inc.

  公开号：EP2301536A1

  公开（公告）日：2011-03-30

  The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.

  本发明涉及通过施用本发明的化合物或组合物治疗或预防与 mRNA 中无义突变相关的疾病的方法、化合物和组合物。更具体地说，本发明涉及抑制与 mRNA 中无义突变相关的过早翻译终止的方法、化合物和组合物。